The MSCI World Healthcare NR Index gained 3.72% in July, outperforming the MSCI World NR by 1.93%. Markets were impacted by inflation figures, which again surprised on the upside. The employment situation continues to improve, to the point that several sectors are struggling to find the workers they need. COVID, particularly the Delta variant, has led to a new bout of volatility, with policymakers across the globe opting for diverging strategies to deal with this latest development of the pandemic.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.